Longitudinal Analysis of Natural Killer Cells in Dengue Virus-Infected Patients in Comparison to Chikungunya and Chikungunya/Dengue Virus-Infected Patients

PLoS Negl Trop Dis. 2016 Mar 3;10(3):e0004499. doi: 10.1371/journal.pntd.0004499. eCollection 2016 Mar.

Abstract

Background: Dengue virus (DENV) is the most prominent arbovirus worldwide, causing major epidemics in South-East Asia, South America and Africa. In 2010, a major DENV-2 outbreak occurred in Gabon with cases of patients co-infected with chikungunya virus (CHIKV). Although the innate immune response is thought to be of primordial importance in the development and outcome of arbovirus-associated pathologies, our knowledge of the role of natural killer (NK) cells during DENV-2 infection is in its infancy.

Methodology: We performed the first extensive comparative longitudinal characterization of NK cells in patients infected by DENV-2, CHIKV or both viruses. Hierarchical clustering and principal component analyses were performed to discriminate between CHIKV and DENV-2 infected patients.

Principal findings: We observed that both activation and differentiation of NK cells are induced during the acute phase of infection by DENV-2 and CHIKV. Combinatorial analysis however, revealed that both arboviruses induced two different signatures of NK-cell responses, with CHIKV more associated with terminal differentiation, and DENV-2 with inhibitory KIRs. We show also that intracellular production of interferon-γ (IFN-γ) by NK cells is strongly stimulated in acute DENV-2 infection, compared to CHIKV.

Conclusions/significance: Although specific differences were observed between CHIKV and DENV-2 infections, the significant remodeling of NK cell populations observed here suggests their potential roles in the control of both infections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Chikungunya Fever / complications*
  • Chikungunya Fever / pathology*
  • Coinfection / pathology
  • Dengue / complications*
  • Dengue / pathology*
  • Female
  • Gabon
  • Humans
  • Killer Cells, Natural / immunology*
  • Longitudinal Studies
  • Male

Grants and funding

This work was supported in part by the Institut National de la Recherche Médicale (INSERM), the Centre National de la Recherche Scientifique (CNRS), and the Université Pierre et Marie Curie, Paris, France. CIRMF is supported by the government of Gabon, Total-Fina-Elf Gabon, and the Ministère des Affaires Etrangères, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.